1191165

AbbVie Inc. — FEI 3009751352

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 6, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Chicago, IL (United States)

Additional Details

Sponsor, Contract Research Organization